Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Costa

Showing results (991-1000 of 1,036) with videos related to

Pageof 104
Sort By:
Chemico-Biological Interactions|September 17, 2021
Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivoAndressa Chequin, Luiz E Costa, Felipe F de Campos, et al.
ACS Pharmacology & Translational Science|December 20, 2021
High-Throughput Screening Reveals New Glutaminase Inhibitor MoleculesRenna K E Costa, Camila T Rodrigues, Jean C H Campos, et al.
Immunobiology|September 30, 2018
Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasisBeatriz C S Salles, Daniel S Dias, Bethina T Steiner, et al.
Frontiers in Microbiology|March 16, 2019
Local Diversification of Methicillin- Resistant <i>Staphylococcus aureus</i> ST239 in South America After Its Rapid Worldwide DisseminationAna Maria Nunes Botelho, Maiana Oliveira Cerqueira E Costa, Ahmed M Moustafa, et al.
Immunobiology|June 6, 2019
A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical proteinDaniela P Lage, Amanda S Machado, Fernanda F Ramos, et al.
Molecular Immunology|December 31, 2018
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infectionPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Parasitology International|February 7, 2018
Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical proteinDaniel S Dias, Patrícia A F Ribeiro, Beatriz C S Salles, et al.
Diagnostic Microbiology and Infectious Disease|June 27, 2018
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-upPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Parasitology|September 11, 2018
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infectionGerusa B Carvalho, Lourena E Costa, Daniela P Lage, et al.
Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Pageof 104

Showing results (991-1000 of 1,036) with videos related to

Sort By:
Pageof 104
Chemico-Biological Interactions|September 17, 2021
Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivoAndressa Chequin, Luiz E Costa, Felipe F de Campos, et al.
ACS Pharmacology & Translational Science|December 20, 2021
High-Throughput Screening Reveals New Glutaminase Inhibitor MoleculesRenna K E Costa, Camila T Rodrigues, Jean C H Campos, et al.
Immunobiology|September 30, 2018
Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasisBeatriz C S Salles, Daniel S Dias, Bethina T Steiner, et al.
Frontiers in Microbiology|March 16, 2019
Local Diversification of Methicillin- Resistant <i>Staphylococcus aureus</i> ST239 in South America After Its Rapid Worldwide DisseminationAna Maria Nunes Botelho, Maiana Oliveira Cerqueira E Costa, Ahmed M Moustafa, et al.
Immunobiology|June 6, 2019
A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical proteinDaniela P Lage, Amanda S Machado, Fernanda F Ramos, et al.
Molecular Immunology|December 31, 2018
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infectionPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Parasitology International|February 7, 2018
Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical proteinDaniel S Dias, Patrícia A F Ribeiro, Beatriz C S Salles, et al.
Diagnostic Microbiology and Infectious Disease|June 27, 2018
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-upPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.
Parasitology|September 11, 2018
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infectionGerusa B Carvalho, Lourena E Costa, Daniela P Lage, et al.
Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.
Pageof 104